M&A Deal Summary

Celling Biosciences Acquires LinkSPINE

On July 1, 2019, Celling Biosciences acquired medical products company LinkSPINE

Acquisition Highlights
  • This is Celling Biosciences’ 2nd transaction in the Medical Products sector.
  • This is Celling Biosciences’ 2nd transaction in the United States.
  • This is Celling Biosciences’ 1st transaction in Maryland.

M&A Deal Summary
Date 2019-07-01
Target LinkSPINE
Sector Medical Products
Buyer(s) Celling Biosciences
Deal Type Add-on Acquisition

Target

LinkSPINE

Columbia, Maryland, United States
LinkSPINE, Inc. is focused upon the development of novel technologies, and in the process has created an innovative portfolio of powerful, yet simple solutions for less invasive spine surgery. LinkSPINE, Inc. offers a whole kit of different innovative spinal fusion devices that require fewer screws, use a smaller exposure, yet guarantee extraordinary strength compared to conventional systems.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Celling Biosciences

Austin, Texas, United States
Category Company
Sector Life Science
DESCRIPTION

Celling Biosciences is a biotech company focused on the science, research and development of autologous cellular therapy. Celling developed the first system on the market that allows users to regulate and select a desired cell type through a patented collection window and integrated ultra-filtration system. Celling is a transformative leader innovating cellular therapy by integrating excellence in research, medical education, advocacy, and product development. Celling Biosciences is based in Austin, Texas.

DEAL STATS #
Overall 2 of 2
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 1 of 1
State (Maryland) 1 of 1
Country (United States) 2 of 2
Year (2019) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-03-04 ThermiGen

Irving, Texas, United States

ThermiGen LLC is a global manufacturer of temperature controlled radiofrequency technology. The company's flagship product is ThermiRF, a platform technology that uses temperature as an endpoint for various minimally and non-invasive applications (ThermiTight, ThermiRase, ThermiSmooth Face, ThermiVa, etc.). Thermi also offers the Thermi250 device as the newest innovative RF for the body. Founded in 2012, Thermi is a US based company with its headquarters in Irving, Texas, and R&D in Boston, MA.

Buy -
Mergr

Product

Company

Legal